SPRY4 and breast cancer: In breast cancer, inhibition of lncRNA PANDAR reduces cancer cell proliferation and invasion (Li and Su Xpan, 2019), while lncRNA SPRY4-IT1 promotes breast cancer cell proliferation and stemness by targeting miR-6882-3p (Song et al., 2019).